2015
DOI: 10.1093/femsre/fuv002
|View full text |Cite
|
Sign up to set email alerts
|

One cannot rule them all: Are bacterial toxins-antitoxins druggable?

Abstract: Type II (proteic) toxin–antitoxin (TA) operons are widely spread in bacteria and archaea. They are organized as operons in which, usually, the antitoxin gene precedes the cognate toxin gene. The antitoxin generally acts as a transcriptional self-repressor, whereas the toxin acts as a co-repressor, both proteins constituting a harmless complex. When bacteria encounter a stressful environment, TAs are triggered. The antitoxin protein is unstable and will be degraded by host proteases, releasing the free toxin to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
98
0
1

Year Published

2015
2015
2020
2020

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 70 publications
(100 citation statements)
references
References 185 publications
(226 reference statements)
1
98
0
1
Order By: Relevance
“…TA systems have recently received much attention as one of the most promising antibacterial targets [90,182,183,184,185] because they are widely distributed in almost all of the most important bacterial pathogens but not in eukaryotic cells. One of the powerful antibacterial strategies is an artificial activation of the toxin, which could be accomplished by using small compounds or peptides as inhibitors of the protein (toxin)-protein (antitoxin) interactions (Figure 9A).…”
Section: Exploitation Of Ta Systems For the Development Of Novel Amentioning
confidence: 99%
“…TA systems have recently received much attention as one of the most promising antibacterial targets [90,182,183,184,185] because they are widely distributed in almost all of the most important bacterial pathogens but not in eukaryotic cells. One of the powerful antibacterial strategies is an artificial activation of the toxin, which could be accomplished by using small compounds or peptides as inhibitors of the protein (toxin)-protein (antitoxin) interactions (Figure 9A).…”
Section: Exploitation Of Ta Systems For the Development Of Novel Amentioning
confidence: 99%
“…Thus, the so-called mobilome (4) participates in the spread of antibiotic resistance, which is expected to cause 10 million casualties annually by 2050, and the consequent huge economic burden (amr-review.org/sites/default/files/Report-52.15.pdf). This has generated a unanimous call for new approaches to deal with infectious diseases caused by pathogenic bacteria (5).…”
mentioning
confidence: 99%
“…Type II TA systems have attracted interest as targets for the development of inhibitors that would prevent binding, thereby freeing the toxin to halt cell growth (36,49). Since models based on crystal structures show that VapB C-terminal domains make extensive contacts with their cognate toxin, the possibility that small molecules could inhibit TA interactions seems limited (7,37,38,40,41).…”
Section: Discussionmentioning
confidence: 99%